Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review
Int. Journal of Clinical Pharmacology and Therapeutics · 01.10.2026 · 64 (10) · 555-558
DOI: 10.5414/cp204982 ↗Kurz gefasst
Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.10.2026. Verfasst von Yu Li und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glycyrrhizic Acid, Mineralocorticoid Excess Syndrome, Apparent, Anti-Inflammatory Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Li, Y., Du, J., & Ma, G. (2026). Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics, 64(10), 555-558. https://doi.org/10.5414/cp204982
Vancouver
Li Y, Du J, Ma G. Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(10):555-558. doi:10.5414/cp204982
BibTeX
@article{Li2026,
author = {Li, Yu and Du, Juan and Ma, Guojie},
title = {Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {10},
pages = {555--558},
doi = {10.5414/cp204982}
}
EUVIMED